Canada: Market and legal data analysis of the cannabis sector

Canada can teach Germany about pitfalls of legalising recreational cannabis

Written by Lorraine Mullaney | 17th June 2022

Germany should plan ahead to avoid problems which have plagued governments that have already legalised recreational cannabis on top of medical cannabis ...

US at risk of missing huge opportunity in cannabis due to lack of federal reform

Written by Lorraine Mullaney | 31st May 2022

The US is in danger of being left behind the burgeoning global cannabis market because of a lack of political will to commit to any form of federal cannabis reform ...

Canada's cannabis industry gathering to urge the government to move faster

Written by CannIntelligence | 25th May 2022

Canada’s cannabis industry is planning a two-day blitz of Parliament Hill in a bid to convince the government to launch its long overdue review of federal cannabis legislation ...

CBD watchdog Leafreport tests sleeping products, with eye-opening results

Written by Lorraine Mullaney | 20th May 2022

The need to improve sleep is one of the main reasons why US consumers buy CBD, according to CBD-Intel’s latest market research; however, a recent report from a CBD watchdog claims that 60% of the...

Survey says Canadian cannabis companies lack consumer awareness

Written by Lorraine Mullaney | 19th May 2022

Canadian cannabis companies are about as well-liked as some of the country’s biggest oil refiners and transporters – a strange position for purveyors of one of the most mellow products on the market ...

THC lookalike products lead packaged goods group to campaign for tougher law

Written by Lorraine Mullaney | 19th May 2022

A small change in proposed legislation could make it significantly easier to prevent the sale of “lookalike” cannabis products that work off existing well-known trademarks ...

New studies explore how cannabis can help improve women’s menstrual health

Written by Lorraine Mullaney | 12th May 2022

Clinical trials are investigating how CBD can improve menstrual health and treat conditions such as premenstrual syndrome (PMS) and perhaps even endometriosis ...

Canadian cannabis firms Hexo and Tilray announce new 'strategic alliance'

Written by Lorraine Mullaney | 10th May 2022

Two major Canadian cannabis producers, Hexo and Tilray Brands, have agreed to form a “strategic alliance”, which involves Tilray acquiring Hexo’s debt in exchange for the right to purchase Hexo shares ...

Aurora expands recreational cannabis portfolio with Thrive acquisition

Written by Lorraine Mullaney | 9th May 2022

Canadian firm Aurora Cannabis is expanding its recreational portfolio with the acquisition of Ontario-based premium cannabis producer Thrive for CAD38m ($29) in cash and Aurora shares ...

Psychedelics and mental health research: hope for public and policy support

Written by Lorraine Mullaney | 27th April 2022

Jamaica is attempting to make itself as synonymous with medical-grade psychedelics in the minds of researchers as it is with cannabis production in the minds of many ...

Tobacco giant BAT increases its stake in cannabis with more cash for Organigram

Written by Lorraine Mullaney | 13th April 2022

British American Tobacco (BAT) has invested a further CAD6.3m (USD5.03m) in the Canadian cannabis company Organigram, thereby increasing its stake from 18.8% to 19.5% ...

Canada's cannabis industry welcomes a federal budget full of good things

Written by CannIntelligence | 11th April 2022

Canada’s cannabis trade is celebrating after the government tabled a budget calling for steps to streamline a variety of tax measures and launch a strategy group to examine ways to grow the industry ...

Will Canadian government's proposal put renewed fizz in cannabinoid drinks?

Written by Lorraine Mullaney | 6th April 2022

Is the Canadian government’s proposal to increase the number of cannabis-infused drinks that can be legally purchased at one time good news for firms that have invested in cannabinoid-infused beverages? ...

Canada’s proposed changes could open up non-therapeutic cannabis research

Written by CannIntelligence | 31st March 2022

The Canadian government is proposing changes to make it easier to conduct non-therapeutic cannabis research in the country and to foster more investigation into the development of cannabis products ...

Israeli companies predict a bright future in plants following regulatory changes

Written by Lorraine Mullaney | 28th March 2022

Regulatory changes in Israel have enabled a cannabis company to advance breeding methods and grow plants that promise to yield higher levels of cannabinoids ...

Canada ready to raise the legal limit on purchases of cannabis-infused drinks

Written by CannIntelligence | 22nd March 2022

The Canadian government is proposing a change in the regulations governing cannabis-infused beverages to increase the number of drinks that can legally be bought at a time ...

The anticipated eBay CBD sales trial has finally launched and is under way

Written by Freddie Dawson | 10th March 2022

The eBay CBD sales trial – first announced by CBD-Intel last year – has finally been confirmed to be underway ...

Is investing in cannabis in 2022 a smart bet or a ‘dead-money scenario’?

Written by Lorraine Mullaney | 9th March 2022

Last month CBD-Intel reported that the Dermapharm Holding bought Canopy Growth’s Cannabinoid Compound Company (C3) for €80m, a huge loss for Canopy, and one of the biggest cannabis acquisitions in Europe at the time. But what makes...

More medical applications for cannabinoids being explored

Written by Lorraine Mullaney | 4th March 2022

Scientists around the world are starting to look even further afield for potential uses of cannabis in medical applications, such as treating the symptoms of long Covid-19, Alzheimer’s-related agitation, and to alleviate the pain resulting...

Early research shows some cannabinoids can prevent Covid-19 infecting cells

Written by CannIntelligence | 3rd February 2022

Research from scientists at the University of Oregon suggests that certain cannabinoids can stop the SARS-CoV-2 (Covid-19) virus from infecting cells. This may lead to future treatments ...

German pharma firm buys €80m C3 to boost its European cannabis presence

Written by CannIntelligence | 26th January 2022

German pharmaceutical manufacturer Dermapharm Holding is paying Canadian cannabis giant Canopy Growth €80m for the Cannabinoid Compound Company (C3) ...

Despite industry investment, the future remains cloudy for cannabinoid drinks

Written by Lorraine Mullaney | 20th January 2022

Covid has significantly increased consumer interest in health and wellness, with food and drink formulations that create innovative solutions for “mental and emotional wellbeing” becoming a 2021 trend ...

CBD’s popularity sparks gold rush to develop rare cannabinoids

Written by Lorraine Mullaney | 19th January 2022

Potential demand for rarer cannabinoids is prompting firms to explore other methods of manufacturing, such as biosynthesis and chemical synthesis, to give higher yields at lower...

How well did we do? CBD-Intel’s predictions for 2021 reviewed

Written by Freddie Dawson | 28th December 2021

CBD-Intel was on point in its 2021 predictions. Much like the preceding year, we believed 2021 would largely be defined more by what did not happen than what did ...

Cannabis companies go on acquisition spree for US stores and tech companies

Written by Lorraine Mullaney | 15th December 2021

Cannabis firms continued to expand their footprint through to the end of 2021, with the lucrative US market being the strategic focus of many acquisitions, covering retail chains and tech companies ...

UK health trust teams up with Awakn to investigate psychedelic treatment

Written by Lorraine Mullaney | 13th December 2021

The UK’s National Health Service (NHS) has expressed some interest in the viability of psychedelics as a course of treatment ...

Couche-Tard tipped for a big future in US CBD retail through its Circle K stores

Written by CannIntelligence | 11th November 2021

It owns one of North America’s biggest chains of convenience stores and fuel stations – now Alimentation Couche-Tard may have the potential to become one of its foremost providers of cannabis and CBD ...

Canadian firm Flora Growth picks Colombia for its cannabis production

Written by CannIntelligence | 22nd October 2021

Toronto-based Flora Growth believes increasing legalisation will eventually lead to cannabis becoming a commodity much like any other crop, and has chosen to focus much of its cannabis production in Colombia ...

Potential for psychedelic treatments prompts big North American buyouts

Written by Lorraine Mullaney | 15th October 2021

Interest in psychedelic drugs and treatments continues to grow, as evidenced by three major takeovers in Canada and the USA, two involving drug treatments developments and another offering a network of ketamine infusion treatment centres...

Personal mental health histories lead to investments in psychedelics research

Written by Lorraine Mullaney | 12th October 2021

Two North American entrepreneurs have put millions of dollars into exploring the treatment efficacy of psychedelics, based on personal experience of using them to help deal with their own mental health issues ...

High Tide enters UK market with £9m purchase of Scotland's Blessed CBD

Written by Freddie Dawson | 11th October 2021

The Canadian cannabis retailer High Tide has made a move into the UK CBD sector by purchasing 80% of the Scottish CBD company Blessed CBD for just over £9m ...

From craft beer to coffee, patience is a virtue in cannabinoid beverages

Written by Lorraine Mullaney | 4th October 2021

Patience continues to be the watchword when it comes to innovation in the cannabinoid beverage space. Developments continue but companies appear willing to take their time to enter the market as regulation loosens ...

Jane Technologies raises $100m to keep rolling out cannabis e-commerce

Written by Lorraine Mullaney | 22nd September 2021

A plan to solve issues with cannabis e-commerce has attracted investors to the tune of around $130m in total ...

Medical use of psilocibyn in Canada could grow, but consumer sale unlikely

Written by CannIntelligence | 13th August 2021

A court case could force the Canadian government to process requests to use psilocybin for psychotherapeutic treatment more...

Investor funding drives company growth and increases cannabis research

Written by Lorraine Mullaney | 11th August 2021

New funding raised from investors will propel cannabis company expansion and research ...

Firm announces mushroom tinctures to launch in UK under Bob Marley brand

Written by CannIntelligence | 9th August 2021

A range of Bob Marley themed functional mushroom tinctures will soon debut in the UK under the Marley One brand ...

Canadian cannabis firms look to the US market as they prepare to expand

Written by Lorraine Mullaney | 6th August 2021

A Canadian cannabis retailer is banking on boosts from cross-selling and increased social media presence to buoy US sales as it gobbles up accessory providers ...

Takeover will enable more research and development towards psychedelic meds

Written by Lorraine Mullaney | 19th July 2021

The Canadian pyschedelics company MagicMed will be taken over by the US firm Enveric Biosciences in a move that will create greater research and development as well as commercialisation opportunities ...

Canada reveals plans to restrict flavours in inhalable cannabis products

Written by CannIntelligence | 25th June 2021

The Canadian government has served notice of plans to restrict flavours in cannabis vaping products and inhaled cannabis extracts across the country, arguing that it will make those products less appealing to youth ...

European ingredient popularity drives cannabinoid sector's latest M&A action

Written by Lorraine Mullaney | 18th June 2021

Appetite for European ingredients producers appears to be driving the latest round of merger and acquisition (M&A) action in the cannabinoid sector ...

UK psychedelics fund puts £5m into seven companies to tackle mental health

Written by CannIntelligence | 14th June 2021

UK venture capital fund Neo Kuma has invested £5m across seven healthcare companies focused on the use of psychedelics to help combat mental health issues ...

Wave of e-commerce and retail store purchases keep High Tide on the rise

Written by Lorraine Mullaney | 1st June 2021

Canadian cannabis retailer High Tide is continuing its advance into the US market with the $26m acquisition of 80% of CBD e-commerce platform Fab Nutrition (FAB CBD) ...

Canopy spreads, while Sundial purchases Canada's largest cannabis retailer

Written by Lorraine Mullaney | 31st May 2021

Merger and acquisition activity remains high in the industry and two major Canadian firms – Sundial Growers and Canopy Growth – have made acquisitions this month ...

Tilray closes deal with Aphria and turns to lobbying for cannabis reform

Written by Lorraine Mullaney | 21st May 2021

The boss of the world’s new largest global cannabis company has likened the industry’s potential to that of the alcohol business before the ending of Prohibition in the early 1930s ...

Growing medical market prompts expansion in New York and Pennsylvania

Written by Lorraine Mullaney | 7th May 2021

When Biden won the US election in November 2020 the stock market value of cannabis firms soared in expectation of a more lenient political climate under the Biden administration ...

Heading south: Valens and Canopy increase presence in US CBD market

Written by Lorraine Mullaney | 6th May 2021

Various business deals across the US and Canada see cannabis and CBD companies expanding their portfolios and growing their brands in a series of acquisitions, investments and partnerships ...

The next big thing – or are investors in psychedelics playing the long game?

Written by CannIntelligence | 19th April 2021

While legal cannabis is still a relatively new industry, investors are already looking for the next sector to boom – and many think that will be psychedelics ...

How cannabis derivatives could help to preserve the miracle of modern medicine

Written by CannIntelligence | 13th April 2021

Could cannabinoids, including CBD, provide a partial solution to the growing danger of diseases becoming resistant to existing antibiotics? ...

US and Australian cannabis companies see great profit potential in Europe

Written by Lorraine Mullaney | 2nd April 2021

There are profits to be made from selling cannabis in Europe, according to US company Curaleaf after it signed an agreement to acquire Europe’s largest vertically integrated independent cannabis company ...

US market to top $3bn in two years, but Swiss remain the biggest CBD users

Written by CannIntelligence | 15th March 2021

Swiss consumers are head-for-head the biggest purchasers of CBD products, according to CBD-Intel’s 2021 market size analysis. Meanwhile, we predict big growth in a number of other markets, and a shift in the most popular...

LATEST ALERTS

Written by Lorraine Mullaney | 17th June 2022

Written by Lorraine Mullaney | 31st May 2022

Written by CannIntelligence | 25th May 2022

Written by Lorraine Mullaney | 20th May 2022

Written by Lorraine Mullaney | 19th May 2022

Written by Lorraine Mullaney | 19th May 2022

Written by Lorraine Mullaney | 12th May 2022

Written by Lorraine Mullaney | 10th May 2022

Written by Lorraine Mullaney | 9th May 2022

Written by Lorraine Mullaney | 27th April 2022

Written by Lorraine Mullaney | 13th April 2022

Written by CannIntelligence | 11th April 2022

Written by Lorraine Mullaney | 6th April 2022

Written by CannIntelligence | 31st March 2022

Written by Lorraine Mullaney | 28th March 2022

Written by CannIntelligence | 22nd March 2022

Written by Freddie Dawson | 10th March 2022

Written by Lorraine Mullaney | 9th March 2022

Written by Lorraine Mullaney | 4th March 2022

Written by CannIntelligence | 3rd February 2022

Written by CannIntelligence | 26th January 2022

Written by Lorraine Mullaney | 20th January 2022

Written by Lorraine Mullaney | 19th January 2022

Written by Freddie Dawson | 28th December 2021

Written by Lorraine Mullaney | 15th December 2021

Written by Lorraine Mullaney | 13th December 2021

Written by CannIntelligence | 11th November 2021

Written by CannIntelligence | 22nd October 2021

Written by Lorraine Mullaney | 15th October 2021

Written by Lorraine Mullaney | 12th October 2021

Written by Freddie Dawson | 11th October 2021

Written by Lorraine Mullaney | 4th October 2021

Written by Lorraine Mullaney | 22nd September 2021

Written by CannIntelligence | 13th August 2021

Written by Lorraine Mullaney | 11th August 2021

Written by CannIntelligence | 9th August 2021

Written by Lorraine Mullaney | 6th August 2021

Written by Lorraine Mullaney | 19th July 2021

Written by CannIntelligence | 25th June 2021

Written by Lorraine Mullaney | 18th June 2021

Written by CannIntelligence | 14th June 2021

Written by Lorraine Mullaney | 1st June 2021

Written by Lorraine Mullaney | 31st May 2021

Written by Lorraine Mullaney | 21st May 2021

Written by Lorraine Mullaney | 7th May 2021

Written by Lorraine Mullaney | 6th May 2021

Written by CannIntelligence | 19th April 2021

Written by CannIntelligence | 13th April 2021

Written by Lorraine Mullaney | 2nd April 2021

Written by CannIntelligence | 15th March 2021

Sign up to our newsletter

Start your FREE trial